In the LIFE trial, regression of electrocardiographic evidence of LVH led to a highly significant reduction of cardiovascular mortality, myocardial infarction, stroke, and the composite end point.
← all excerpts
Hypertension and Diabetes: what are the pros to treating early surrogates?
1
—
—